Bryan Sisk
Pediatric Hematology-Oncology · Saint Louis, MONPI 1073953667
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $5,365 of the $5,600 with a category attached, or 95.8%.
Across 6 payments — averaging $933.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis Pharma AG$3K
- Novartis$2K
Across 13 payments — averaging $394,183 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Novartis$5.1M
- Novartis Pharma AG$1K
What the payments were for
- Consulting fees$5,36596%
- Food & beverage$2354%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novartis Pharma AG | 1 | $3,125 |
| Novartis | 5 | $2,475 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VIJOICE$5,365
How this compares
$5,600 in reported general payments places this provider in the 80th percentile of 78 pediatric hematology-oncology providers in Missouri.
See all pediatric hematology-oncology providers in Missouri →
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| VijoiceAlpelisib | 12 | $370,333 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| NovartisVijoice | $2,475 | $370,33312 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 78 pediatric hematology-oncology providers in Missouri.
Other pediatric hematology-oncology in Saint Louis
- Mohamed AbdelbakiSaint Louis$50K
- Amy ArmstrongSaint Louis$42K
- Melanie FieldsSaint Louis$29K
- Shalini ShenoySaint Louis$25K
- Jeffrey BednarskiSaint Louis$11K
- Nicole BrossierSaint Louis$11K
- Jorge DipaolaSaint Louis$6K
- Michael Angelo HuangSaint Louis$4K
- William FergusonSaint Louis$4K
- Jeffrey MageeSaint Louis$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.